Weight Loss Articles - Page 90

Meijer Reduces Out-of-Pocket Costs for GLP-1 Meds Like Ozempic, Wegovy

Meijer is making GLP-1 medications more affordable by accepting manufacturer savings programs for Ozempic and Wegovy, dropping costs to $199 per month for the first two months on lowest doses. The retailer also offers the newly approved oral Wegovy through the same program, starting at $149 out-of-pocket. This move aims to boost access to these popular weight loss injections amid rising demand.

Shotlee·Feb 10, 2026·5 min read

GLP-1 Medications

Meat Snacks Boom in GLP-1 Shift Like Ozempic, Popcorn Declines

Meat snacks have become the standout winner in America's GLP-1 consumption shift, surging to a $5.5 billion market as Ozempic and Wegovy users crave protein. Popcorn sales are plummeting amid this protein obsession. Discover the data, expert analysis, and how it's changing snacking habits.

Shotlee·Feb 10, 2026·5 min read

Celebrity Health & GLP-1 Insights

Simon Cowell's 'Ozempic Face' Sparks Fan Speculation

Simon Cowell's latest video before the Britain's Got Talent 2025 finale has fans convinced he's developing 'Ozempic face' due to his noticeably slimmer features and changed eye shape. Social media erupts with comments from 2023 to 2025, even linking him to Ryan Seacrest's look. Despite the buzz, Cowell tells The Sun he's never tried Ozempic.

Shotlee·Feb 10, 2026·5 min read

GLP-1 Regulatory News

Novo Nordisk Sues Hims & Hers Over Semaglutide Patent

Novo Nordisk has filed a lawsuit against Hims & Hers Health Inc., accusing the telehealth company of breaching its U.S. patent on semaglutide used in blockbuster obesity drugs like Ozempic and Wegovy. Despite Hims scrapping plans for a copycat Wegovy pill, Novo claims the compounded versions remain dangerous and infringing. This legal battle highlights growing tensions over compounded GLP-1 drugs post-shortage.

Shotlee·Feb 10, 2026·5 min read

Patient Safety

Mum Dies Days After £20 Unregulated Skinny Jab: Family Demands Change

A mother's heartbreaking death after a cheap black market 'skinny jab' has sparked a family's campaign for tougher regulations. Karen McGonigal passed away days after receiving unregulated semaglutide at a beauty salon. Now, her daughters are urging the government to act before more lives are lost.

Shotlee·Feb 10, 2026·6 min read

GLP-1 Medications

China Biotech Targets 2028 Trials for Semaglutide Nasal Spray Like Wegovy

A Shanghai-based biotech is developing a nasal spray version of semaglutide, the key ingredient in Novo Nordisk's Wegovy, with global clinical trials targeted for completion by 2028. This experimental weight-management spray promises lower costs than tablets and better suitability for long-term use. As Novo's patent nears expiration in China, competition heats up in the booming GLP-1 market.

Shotlee·Feb 10, 2026·4 min read

GLP-1 Medications

Oral GLP-1s Benefit HF Patients: SOUL Trial Subanalysis

A subanalysis of the SOUL trial reveals that once-daily oral semaglutide (Rybelsus) lowers the risk of heart failure hospitalization, urgent visits, or CV death by 22% in patients with HF, diabetes, and ASCVD or CKD. Those with preserved ejection fraction (HFpEF) saw even greater protection at 41%. Experts highlight this as a key option for frail patients avoiding injections.

Shotlee·Feb 9, 2026·6 min read

GLP-1 Medications

Oral Semaglutide Reduces Heart Failure Risk in Type 2 Diabetes: SOUL Trial

New analysis from the SOUL trial reveals oral semaglutide significantly reduces heart failure risks in type 2 diabetes patients who already have the condition. This benefit is especially notable in HFpEF cases, without compromising safety. Discover the details and implications for managing cardiometabolic disease.

Shotlee·Feb 8, 2026·5 min read

Events & Nutrition

GLP-1 Era Nutrition Symposium on Cardiac Recovery Held in Dhaka

A pivotal symposium on 'Nutrition in Clinical Practice: From GLP-1 Era to Cardiac Recovery' drew 150 nutrition professionals to Dhaka's KIB Convention Hall. Chaired by renowned dietician Akhtarun Nahar Alo, the event featured keynote speakers from NICVD and BIRDEM, followed by the launch of Nutricaa Limited's OPTIMA meal replacement. This gathering highlights the growing intersection of GLP-1 therapies and targeted nutrition for cardiac recovery.

Shotlee·Feb 8, 2026·5 min read

Weight Loss

Latest Articles

Meijer Reduces Out-of-Pocket Costs for GLP-1 Meds Like Ozempic, Wegovy

Meat Snacks Boom in GLP-1 Shift Like Ozempic, Popcorn Declines

Simon Cowell's 'Ozempic Face' Sparks Fan Speculation

Novo Nordisk Sues Hims & Hers Over Semaglutide Patent

Mum Dies Days After £20 Unregulated Skinny Jab: Family Demands Change

China Biotech Targets 2028 Trials for Semaglutide Nasal Spray Like Wegovy

Oral GLP-1s Benefit HF Patients: SOUL Trial Subanalysis

Oral Semaglutide Reduces Heart Failure Risk in Type 2 Diabetes: SOUL Trial

GLP-1 Era Nutrition Symposium on Cardiac Recovery Held in Dhaka

People Taking GLP-1 Weight Loss Drugs Like Ozempic and Wegovy Started Moving Less

Ozempic, Mounjaro & More: Yale Study Exposes Risky Online GLP-1 Prescribing

Beyond Healthspan: The New Midlife Goal for Men

GLP-1 Drugs Linked to Skin Pain: New Reports of Dysesthesia & Allodynia

Ozempic and Similar Weight-Loss Medications Linked to 30% Lower Breast Cancer Risk